Coloplast announced today that it entered into an agreement to sign Kerecis, a developer of biologics for the wound care market. The agreement has a total value reaching up to $1.3 billion. Of that, Coloplast intends to pay $1.2 billion in an upfront cash payment. Denmark-based Coloplast sees Kerecis as an “attractive opportunity” to strengthen […]
Kerecis
FDA approves Kerecis Omega3 SecureMesh fish-skin surgical mesh
Kerecis said today that it won 510(k) clearance from the FDA for its Kerecis Omega3 SecureMesh regenerative surgical mesh for use in lung, bariatric, gastric, colorectal and other surgeries. The McLean, Va.-based company said the Kerecis Omega3 mesh is made from intact fish skin saturated in naturally occurring Omega3 polyunsaturated fatty acids. Kerecis said the material […]